It is a pharma private limited company based in Chennai, Tamil Nadu, India, established in 2004.
2004 | Chennai, Tamil Nadu, India | ActiveDeo Pharmaceuticals Private Limited, a active private limited company, was established on 06 December 2004 in Chennai, Tamil Nadu, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U24231TN2004PTC054831. Registered under ROC Roc Chennai. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹0.74 M.
It upholds a compliant status. Its leadership includes Somasekharan Sureshbabu (Director), Ramalingaiyar Sadhanantham (Director), Jayanthi (Alternate Director). Past directors included Perumal Pillai Somasekharan, Ramalingaiyar Sadhanantham. It holds ₹1.17 Cr open charges and no settled loans. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at No.60/61,Krishna Industrial Estate, Vanagaram Mettukuppam, Chennai, Tamil Nadu, 600095.
U24231TN2004PTC054831
054831
06 December 2004
₹1.00 M
₹0.74 M
Roc Chennai
Unlisted
Active
Explore comprehensive insights into Deo Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Somasekharan Sureshbabu | Director | 06 Dec 2004 | Current |
| Ramalingaiyar Sadhanantham | Director | 12 Jan 2007 | Current |
| Jayanthi | Alternate Director | 06 May 2025 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 31 Mar 2020 | Past |
| Pramod Abcsdd | Additional Director | 29 Sep 2012 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Deo Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 43.84% increase. The company also saw a substantial fall in profitability, with a 32.87% decrease in profit. The company's net worth observed a substantial decline by a decrease of 12.11%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Deo Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
₹11,680,000.00
₹0
| Date | Lender | Amount | Status |
|---|---|---|---|
| 21 Nov 2019 | State Bank Of India | ₹4.90 M | Open |
| 23 Mar 2010 | State Bank Of Travancore | ₹0.72 M | Open |
| 08 Aug 2007 | State Bank Of Travancore | ₹0.61 M | Open |
| 02 Jun 2007 | State Bank Of Travancore | ₹4.70 M | Open |
| 26 May 2007 | State Bank Of Travancore | ₹0.75 M | Open |
Explore comprehensive loan charge details -
Unlock and access historical data on people associated with Deo Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Deo Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Deo Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Progress on Jayanthi was appointed as a Alternate Director was appointed as a Alternate Director on 06 May 2025 & has been associated with this company since 6 months 27 days . was documented.
The activity Deo Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Progress on Deo Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Chennai. was documented.
A charge with State Bank Of India amounted to Rs. 4.90 M with Charge ID 100306349 was registered on 21 Nov 2019. was recorded as a recent event.
A charge with State Bank Of Travancore of Rs. 4.70 M registered on 02 Jun 2007 with Charge ID 10073752 was modified on 23 Mar 2015. was recorded as a recent event.
Progress on A charge with State Bank Of Travancore amounted to Rs. 0.72 M with Charge ID 10214694 was registered on 23 Mar 2010. was documented.
The CIN of Deo Pharmaceuticals Private Limited is U24231TN2004PTC054831.
Deo Pharmaceuticals Private Limited is headquartered at No.60/61,Krishna Industrial Estate, Vanagaram Mettukuppam, Chennai, Tamil Nadu, 600095.
Deo Pharmaceuticals Private Limited was incorporated on 06 December 2004.
The current directors of Deo Pharmaceuticals Private Limited are
The primary industry of Deo Pharmaceuticals Private Limited is Manufacturing.
Deo Pharmaceuticals Private Limited is unlisted.
The authorized capital of Deo Pharmaceuticals Private Limited is ₹1.00 M, and the paid-up capital is ₹0.74 M.
The compliance status of Deo Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX